0001077183-21-000278.txt : 20211230
0001077183-21-000278.hdr.sgml : 20211230
20211230180503
ACCESSION NUMBER: 0001077183-21-000278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211230
FILED AS OF DATE: 20211230
DATE AS OF CHANGE: 20211230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mallon Mark
CENTRAL INDEX KEY: 0001763533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 211533931
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
BUSINESS PHONE: 2397680600
MAIL ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_164090548763134.xml
FORM 4
X0306
4
2021-12-30
0
0001077183
NEOGENOMICS INC
NEO
0001763533
Mallon Mark
9490 NEOGENOMICS WAY
FORT MYERS
FL
33912
1
1
0
0
Chief Executive Officer
Common Stock
2021-12-30
4
A
0
152858
0
A
225594
D
Stock Option (Right to Buy)
49.34
2028-04-19
Common Stock
151016.0
151016
D
On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Mark W. Mallon
2021-12-30